Among these factors, high BMI, male gender, old age, and high ALT levels were commonly reported to be positively associated with NAFLD in CHB patients (Peng et al., 2008; Shi et al., 2008; Zheng et al., 2010; Machado et al., 2011; Wong et al., 2012; Cheng et al., 2013; Wang et al., 2014, 2019; Enomoto et al., 2016; Charatcharoenwitthaya et al., 2017; Joo et al., 2017; Chen et al., 2018; Hui et al., 2018; Zhong et al., 2018; Zhu et al., 2019). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.